NASDAQ$AMED
Amedisys Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Amedisys reported a net loss attributable to Amedisys, Inc. of $80.3 million, which is inclusive of $125.5 million in costs associated with merger transactions, compared to net income attributable to Amedisys, Inc. of $29.6 million in 2022.
Amedisys, Inc. reported a decrease in net service revenue to $553.0 million compared to $557.9 million in 2022. The company experienced a net loss attributable to Amedisys, Inc. of $80.3 million, inclusive of merger-related costs, contrasting with a net income of $29.6 million in the previous year. Adjusted EBITDA was $74.6 million, slightly up from $74.4 million in 2022.
- Net service revenue decreased by $4.9 million year-over-year to $553.0 million.
- Net loss attributable to Amedisys, Inc. was $80.3 million, impacted by $125.5 million in merger transaction costs.
- Adjusted EBITDA increased slightly to $74.6 million from $74.4 million in the prior year.
- The company has suspended guidance on 2023 financial performance due to the pending merger with UnitedHealth Group Incorporated.
Headline financials
Revenue & EPS history
Amedisys · Revenue · Quarterly
$553M
Forward guidance
Amedisys has decided to suspend providing forward guidance on 2023 financial performance due to the pending merger with UnitedHealth Group Incorporated.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 15 quarterly earnings reports · overlaid with Q2 2023
-0.6%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-5.0%
Avg return
30 days after
46%
32 / 70 earnings
Positive
+25.6%
Q2 2014
Best reaction
-25.3%
Q3 2013
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | — | — | — | |
| Q3 2025 | — | — | — | |
| Q2 2025 | +1.2% | +1.0% | — | |
| Q1 2025 | +0.2% | -0.8% | -1.6% | |
| Q4 2024 | +0.1% | +0.6% | +1.5% | |
| Q3 2024 | +0.9% | -3.4% | -10.4% | |
| Q2 2024 | +0.0% | +0.5% | -0.2% | |
| Q1 2024 | +0.0% | +0.8% | +5.5% | |
| Q4 2023 | +0.9% | +0.6% | -1.6% | |
| Q3 2023 | -0.8% | -1.1% | +1.8% | |
| Q2 2023 | -0.6% | -0.2% | +2.5% | |
| Q1 2023 | +4.2% | +3.9% | +2.8% | |
| Q4 2022 | +5.4% | +2.2% | -23.6% | |
| Q3 2022 | -9.0% | -4.2% | -10.7% | |
| Q2 2022 | -3.8% | +0.9% | -4.5% | |
| Q1 2022 | +0.4% | -3.3% | -10.5% | |
| Q4 2021 | +5.8% | +14.5% | +18.4% | |
| Q3 2021 | +0.1% | +1.7% | -20.2% | |
| Q2 2021 | -22.8% | -22.9% | -29.3% | |
| Q1 2021 | +0.2% | — | — | |
| Q4 2020 | -6.2% | — | — | |
| Q3 2020 | -1.9% | — | — | |
| Q2 2020 | +3.7% | — | — | |
| Q1 2020 | -3.3% | — | — | |
| Q4 2019 | -2.1% | — | — | |
| Q3 2019 | -1.5% | — | — | |
| Q2 2019 | -1.9% | — | — | |
| Q1 2019 | -6.3% | — | — | |
| Q4 2018 | +0.0% | — | — | |
| Q3 2018 | +17.3% | — | — | |
| Q2 2018 | +11.1% | — | — | |
| Q1 2018 | +7.2% | — | — | |
| Q4 2017 | +2.3% | — | — | |
| Q3 2017 | +4.8% | — | — | |
| Q2 2017 | -20.9% | — | — | |
| Q1 2017 | +4.4% | — | — | |
| Q4 2016 | +4.7% | — | — | |
| Q3 2016 | -10.1% | — | — | |
| Q2 2016 | -7.1% | — | — | |
| Q1 2016 | -7.0% | — | — | |
| Q4 2015 | +12.3% | — | — | |
| Q3 2015 | +10.8% | — | — | |
| Q2 2015 | -3.2% | — | — | |
| Q1 2015 | +6.0% | — | — | |
| Q4 2014 | -5.4% | — | — | |
| Q3 2014 | +16.2% | — | — | |
| Q2 2014 | +25.6% | — | — | |
| Q1 2014 | -1.0% | — | — | |
| Q4 2013 | -10.0% | — | — | |
| Q3 2013 | -25.3% | — | — | |
| Q2 2013 | +17.8% | — | — | |
| Q1 2013 | -2.8% | — | — | |
| Q4 2012 | -8.7% | — | — | |
| Q3 2012 | -5.0% | — | — | |
| Q2 2012 | +12.5% | — | — | |
| Q1 2012 | -1.2% | — | — | |
| Q4 2011 | -0.6% | — | — | |
| Q3 2011 | -23.8% | — | — | |
| Q2 2011 | -10.7% | — | — | |
| Q1 2011 | -6.4% | — | — | |
| Q4 2010 | -8.0% | — | — | |
| Q3 2010 | +1.3% | — | — | |
| Q2 2010 | -7.9% | — | — | |
| Q1 2009 | -4.3% | — | — | |
| Q1 2010 | +2.6% | — | — | |
| Q4 2007 | -1.3% | — | — | |
| Q4 2009 | -1.3% | — | — | |
| Q3 2008 | -5.7% | — | — | |
| Q3 2009 | -5.7% | — | — | |
| Q4 2008 | +7.6% | — | — | |
| Q2 2008 | +7.6% | — | — | |
| Q2 2009 | +7.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro